GNH USA

Europe — EMA

Iprabronch

GNH USA supplies Iprabronch (Ipratropium Bromide), a bronchodilator for COPD and asthma, meeting EU quality standards. Request a quote for global supply.

Ipratropium Bromide

Request sourcing

1
Pack/s

What is Ipratropium Bromide?

Ipratropium bromide, the active ingredient in Iprabronch, is an anticholinergic (muscarinic antagonist) presented as an inhalation formulation for inhalation use. It is employed to relieve bronchoconstriction and reduce mucus secretion in patients with chronic obstructive pulmonary disease (COPD) and asthma. By competitively blocking muscarinic receptors in airway smooth muscle, it helps open the airways and improve breathing.

GNH USA supplies Iprabronch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ipratropium Bromide used for?

Ipratropium bromide is a bronchodilator used in the management of obstructive airway diseases.

- Chronic obstructive pulmonary disease (COPD): improves airflow and reduces exacerbations. - Asthma: provides additional bronchodilation when combined with other agents. - Bronchospasm (acute): relieves sudden airway narrowing and eases breathing.

What are the side effects of Ipratropium Bromide?

Ipratropium bromide may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth. - Cough or throat irritation. - Hoarseness. - Headache. - Nausea. - Taste disturbance.

Serious or Rare Side Effects: - Paradoxical bronchospasm. - Severe allergic reaction (rash, angioedema, anaphylaxis).

What precautions apply to Ipratropium Bromide?

When prescribing Iprabronch, consider patient‑specific factors and monitor for potential complications.

- Renal impairment: monitor renal function as the drug is excreted unchanged. - Pregnancy: use only if the benefit outweighs the potential risk. - Elderly patients: observe for urinary retention or constipation. - Concomitant anticholinergic therapy: may increase anticholinergic burden. - Store at room temperature: keep in the original container, protect from moisture and light.

What does Ipratropium Bromide interact with?

Iprabronch can interact with other medications; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Other inhaled anticholinergics: risk of additive anticholinergic effects. - Beta‑blockers: may diminish bronchodilator response.

Moderate Interactions (Monitor Closely): - Oral antihistamines: may increase dry mouth. - Theophylline: monitor for altered serum levels. - MAO inhibitors: observe for potential cardiovascular effects.

Frequently asked questions

What is Iprabronch used for?+
Iprabronch contains ipratropium bromide, an inhaled anticholinergic bronchodilator indicated for the long‑term management of chronic obstructive pulmonary disease (COPD) and for adjunct therapy in asthma. It works by relaxing airway smooth muscle and reducing mucus secretion, helping improve airflow and relieve symptoms such as wheezing and shortness of breath.
How does ipratropium bromide work?+
Ipratropium bromide acts as a competitive antagonist at muscarinic (M1 and M3) acetylcholine receptors located on airway smooth muscle and sub‑mucosal glands. By blocking acetylcholine binding, it prevents bronchoconstriction and decreases secretions, resulting in bronchodilation and clearer airways.
What is the usual dose of Iprabronch?+
The specific dose and frequency of Iprabronch are determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Healthcare professionals select the appropriate inhalation regimen and device according to approved labeling and individual therapeutic needs.
Is Iprabronch safe during pregnancy or breastfeeding?+
Safety data for ipratropium bromide in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.
How do I order Iprabronch from GNH USA?+
To request Iprabronch, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Iprabronch compare with other bronchodilators?+
Iprabronch (ipratropium bromide) belongs to the anticholinergic class, whereas many alternatives such as albuterol are β2‑agonists. Anticholinergics provide longer‑lasting bronchodilation with a lower risk of tachycardia, but may cause dry mouth. In practice, ipratropium is often combined with β2‑agonists for additive effect, especially in moderate‑to‑severe COPD.
How should Iprabronch be stored and handled?+
Iprabronch should be stored at room temperature, below 25 °C, in its original container to protect it from moisture, heat and light. The inhalation device should be kept clean, and any unused portion should be discarded according to local regulations after the indicated expiry date.
How is Iprabronch administered?+
Iprabronch is delivered via inhalation using a metered‑dose inhaler or nebulizer, as specified on the product label. The patient inhales the prescribed number of puffs or nebulized dose, typically holding the breath for a few seconds to allow optimal drug deposition in the lower airways. Proper technique should be taught by a healthcare professional.
What are the most serious risks associated with Iprabronch?+
Although uncommon, serious adverse reactions can include paradoxical bronchospasm, severe allergic responses such as angio‑edema or anaphylaxis, and urinary retention or glaucoma exacerbation in susceptible individuals. Any sudden worsening of breathing, rash, swelling of the face or throat, or difficulty urinating should prompt immediate medical evaluation.
Who should not use Iprabronch?+
Iprabronch is contraindicated in patients with known hypersensitivity to ipratropium bromide or any of the inhaler excipients. Caution is advised in individuals with narrow‑angle glaucoma, urinary retention, or severe obstructive uropathy, as anticholinergic effects may worsen these conditions. A healthcare professional should assess suitability before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ipratropium Bromide
Route
Inhalation Use
Manufacturer
Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU